Zoetis Inc header image

Zoetis Inc

ZTS

Equity

ISIN null / Valor 19276994

New York Stock Exchange, Inc (2026-02-27)

USD 131.10+1.03%

Zoetis Inc
UMushroom community rating:

3.36 5 votes No rating yet

NegativeNeutralPositive

About company

Zoetis Inc. is a global leader in the animal health industry, providing a comprehensive range of products and services that cater to the health needs of animals. With operations spanning over 100 countries, the company's portfolio encompasses a wide array of medicines, vaccines, diagnostics, and technologies designed to support the health and well-being of animals across various sectors, including livestock and companion animals. Zoetis is recognized for its innovative approach in developing solutions that address both common and emerging health challenges faced by animals, thereby contributing significantly to the global animal health sector. The company's commitment to research and development is evident in its robust pipeline, which ensures a continuous introduction of new and improved products to the market, further solidifying its position as a key player in the animal health industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-20.5%1Y

-20.8%3Y

-15.6%5Y

Performance

29.5%1Y

26.5%3Y

26.8%5Y

Volatility

55341 M

Market cap (USD)

5,546,407

Daily traded volume (Shares)

163.89 / 161.59

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.36

5 votes

Performance:

3.09

Innovation:

3.82

Society:

4.00

Nature:

4.00

Noah Juganar

United Kingdom, 23 Oct 2025

Solid fundamentals in financials & competitive advantages

D X

Switzerland, 16 Apr 2025

Langfristige Chance

D X

Switzerland, 29 Mar 2025

Ein Unternehmen, das meiner Meinung nach in einem zukunftsträchtigen Markt vorne mit dabei ist.

EQUITIES OF THE SAME SECTOR

Inari Medical Inc

Inari Medical Inc Valor: 52764794

Annual Return

-50%0%+50%

Risk level

110

0.00%USD 79.97

Alcon Inc.

Alcon Inc. Valor: 43249246

Annual Return

-50%0%+50%

Risk level

110

0.15%CHF 66.86

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

1.45%CHF 59.40

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

-3.23%CHF 18.60

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

-5.89%EUR 225.20

bioMerieux SA

bioMerieux SA Valor: 38147803

Annual Return

-50%0%+50%

Risk level

110

3.73%EUR 100.00

Siemens Healthineers AG

Siemens Healthineers AG Valor: 40652181

Annual Return

-50%0%+50%

Risk level

110

-0.59%EUR 42.14

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

-0.82%EUR 50.90

Fresenius Medical Care AG

Fresenius Medical Care AG Valor: 520878

Annual Return

-50%0%+50%

Risk level

110

0.59%EUR 39.45

Evolent Health Inc

Evolent Health Inc Valor: 28153126

Annual Return

-50%0%+50%

Risk level

110

-2.11%USD 3.25

SIX

FactSet

Clearbit

Logos provided by Clearbit